Yung Zip Chemical Ind. Co., Ltd. (TPEX:4102)
20.15
-0.35 (-1.71%)
Feb 11, 2026, 1:33 PM CST
Yung Zip Chemical Ind. Revenue
Yung Zip Chemical Ind. had revenue of 104.16M TWD in the quarter ending September 30, 2025, a decrease of -33.50%. This brings the company's revenue in the last twelve months to 462.64M, down -26.73% year-over-year. In the year 2024, Yung Zip Chemical Ind. had annual revenue of 583.70M with 4.39% growth.
Revenue (ttm)
462.64M
Revenue Growth
-26.73%
P/S Ratio
1.85
Revenue / Employee
2.46M
Employees
188
Market Cap
853.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 583.70M | 24.54M | 4.39% |
| Dec 31, 2023 | 559.15M | -8.18M | -1.44% |
| Dec 31, 2022 | 567.33M | 89.74M | 18.79% |
| Dec 31, 2021 | 477.60M | 14.38M | 3.11% |
| Dec 31, 2020 | 463.21M | 46.38M | 11.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Healthconn | 1.20B |
| Concord Medical | 905.31M |
| Radiant Innovation | 413.06M |
| Ttbio | 392.72M |
| S&S Healthcare Holding | 205.64M |
| PlexBio | 153.06M |